Samuele Caruggi
Biographic Data
| ID | 7622124 |
|---|---|
| NAME | Samuele Caruggi |
| GIVEN NAMES | Samuele |
| FAMILY NAME | Caruggi |
| SIGNATURE | CARUGGI S |
| AFFILIATIONS | Istituto Giannina Gaslini |
| ORCID | 0000-0003-2928-7220 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Second Attempt for Patent Ductus Arteriosus (PDA) Closure
Background : The diagnosis of hemodynamically significant patent ductus arteriosus (hsPDA) occurs in 55% of very low birth weight (VLBW) preterm infants. There is no agreement on the best approach to ensure a quick hsPDA closure. Drug treatment of hsPDA fails in approximately 20% of cases with an increasing risk of prolonged ventilation, BPD, and NEC, as well as the need for surgical duct ligation. This study aims to highlight the efficacy of ibu…
Do Different Amounts of Exogenous Surfactant Differently Influence Cerebrovascular Instability in a Consecutive Group of Preterm Babies? Preliminary Results from a Single-Center Experience
Our data obtained from the group with > 3 fractionated doses of ES seem to justify the preparation of a more robust study, as the combination of reduced NIRS variability and reduced tCO 2 maximum levels is consistent with more stable cerebral blood flow during the challenging time of ES administration
No prominent works on this page.
Do Different Amounts of Exogenous Surfactant Differently Influence Cerebrovascular Instability in a Consecutive Group of Preterm Babies? Preliminary Results from a Single-Center Experience
Our data obtained from the group with > 3 fractionated doses of ES seem to justify the preparation of a more robust study, as the combination of reduced NIRS variability and reduced tCO 2 maximum levels is consistent with more stable cerebral blood flow during the challenging time of ES administration
Second Attempt for Patent Ductus Arteriosus (PDA) Closure
Background : The diagnosis of hemodynamically significant patent ductus arteriosus (hsPDA) occurs in 55% of very low birth weight (VLBW) preterm infants. There is no agreement on the best approach to ensure a quick hsPDA closure. Drug treatment of hsPDA fails in approximately 20% of cases with an increasing risk of prolonged ventilation, BPD, and NEC, as well as the need for surgical duct ligation. This study aims to highlight the efficacy of ibu…
Anesthesia (2 works) · Medicine (2 works) · Pediatrics (2 works) · Acetaminophen (1 works) · Acidosis (1 works) · Cardiovascular Conditions and Treatments (1 works) · Cerebral blood flow (1 works) · Chemistry (1 works) · Congenital Heart Disease Studies (1 works) · Ductus arteriosus (1 works)